𝔖 Bobbio Scriptorium

✦ LIBER ✦

259 Evaluation of the observance of inhaled tobramycin (Tobi®), by comparing the duration of dispensary delivery with the medical prescription in cystic fibrosis

Book ID: 118640387
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 98 KB
Volume: 4
Category: Article
ISSN: 1569-1993
DOI: 10.1016/s1569-1993(05)80233-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Savings in direct medical costs from the

Savings in direct medical costs from the use of tobramycin solution for inhalation in patients with cystic fibrosis

✍ Jacques LeLorier; Sylvie Perreault; Howard Birnbaum; Paul Greenberg; Odile Sheeh 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 776 KB

WS5.5 A randomised, open label phase 3 s

WS5.5 A randomised, open label phase 3 study to evaluate the efficacy and safety of a dry powder formulation of inhaled colistimethate sodium (Colobreathe®) versus tobramycin nebuliser solution (TNS) in cystic fibrosis subjects with chronic Pseudomonas aeruginosa lung infection

✍ M. Goldman; A. Schuster; C. Halliburn; G. Döring 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB